T1	p 25 41	prostatic cancer
T2	p 162 213	previously untreated patients with prostatic cancer
T3	p 623 696	patients with advanced disease no longer responsive to hormonal treatment
T4	i 243 255	Stilboestrol
T5	i 263 282	Cyproterone acetate
T6	i 290 317	Medroxyprogesterone acetate
T7	i 343 355	Stilboestrol
T8	i 363 371	Estracyt
T9	i 473 485	Stilboestrol
T10	i 723 733	Adriamycin
T11	i 737 749	Procarbazine
T12	i 807 819	Procarbazine
T13	o 562 574	side effects
T14	o 586 599	gynaecomastia
T15	o 752 776	Toxicity and early death